Exocrine Pancreatic Insufficiency and Functional Dyspepsia

Not yet recruitingOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

August 1, 2026

Conditions
Exocrine Pancreatic InsufficiencyDyspepsia
Interventions
DIAGNOSTIC_TEST

fecal elastase

To investigate exocrine pancreatic insufficiency (EPI), all patients will be asked to provide a stool sample for fecal elastase (Fel-1) analysis. Participants will be instructed to collect their stool sample in a sterile, disposable plastic container and submit it to the Gastroenterology Chemistry Laboratory (Litwin Laboratory) for processing and analysis. Based on previously published reports, samples will be refrigerated at 4-8 °C for no more than 48 hours. The concentration of Fel-1 in all samples will be measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (ScheBo-Pancreatic Elastase 1™, Giessen, Germany), with fecal elastase extracted and analyzed according to the manufacturer's instructions.

DIAGNOSTIC_TEST

Serum cytokines

Cytokines will be quantified using the Bio-Plex Pro™ Human Cytokine 27-plex commercial kit (Bio-Rad Laboratories, USA) following the kit instructions.

All Listed Sponsors
lead

Maria Marta Piskorz

OTHER

NCT06756503 - Exocrine Pancreatic Insufficiency and Functional Dyspepsia | Biotech Hunter | Biotech Hunter